Medicine and Dentistry
Patient
100%
Drug-Eluting Stent
44%
Stent
43%
Percutaneous Coronary Intervention
37%
Lesion
31%
Inpatient
30%
Myocardial Infarction
29%
Follow up
20%
Therapeutic Procedure
19%
ST Segment Elevation Myocardial Infarction
18%
Zotarolimus
16%
Analysis
16%
Pooled Analysis
15%
Everolimus
12%
Woman
12%
Polymer
12%
Chemotherapeutic Agent
12%
Drug
12%
Metal
11%
Heart Death
10%
Assessment
10%
Intravascular Ultrasound
9%
Target Lesion Revascularization
9%
Plaque
9%
Primary Percutaneous Coronary Intervention
9%
Target Lesion
9%
Coronary Artery Disease
9%
Man
8%
Mortality
8%
Rapamycin
7%
Stent Thrombosis
7%
Optical Coherence Tomography
7%
Acute Coronary Syndrome
7%
Element
7%
Hazard Ratio
7%
Fractional Flow Reserve
7%
Diabetes Mellitus
7%
Measurement
6%
Coronary Artery
6%
Acute Heart Infarction
6%
Ticagrelor
6%
Target Vessel Revascularization
5%
Antiplatelet
5%
Combination Therapy
5%
Cardiovascular System
5%
Revascularization
5%
Infarction
5%
Diabetes
5%
Stenosis
5%
Thorax Pain
5%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
30%
Stent
28%
Heart Infarction
17%
Polymer
16%
Zotarolimus
12%
Everolimus
11%
Metal
8%
Element
7%
Heart Death
7%
Stent Thrombosis
6%
Coronary Artery Disease
6%
Sirolimus
6%
ST Segment Elevation Myocardial Infarction
5%
Acute Heart Infarction
5%